Pawel Baranczewski
Researcher at Department of Pharmacy; UDOPP
- Telephone:
- +46 18 471 40 67
- E-mail:
- pawel.baranczewski@uu.se
- Visiting address:
- Biomedicinskt Centrum BMC, Husargatan 3
- Postal address:
- Box 580
751 23 UPPSALA
Download contact information for Pawel Baranczewski at Department of Pharmacy; UDOPP
- CV:
- Download CV
Short presentation
Associate Professor (Docent) in preclinical drug development. Head of the UDOPP (Uppsala University Drug Optimization and Pharmaceutical Profiling) local platform at the Department of Pharmacy, and the ADME of Therapeutics (ADMEoT) national facility within SciLifeLab Drug Discovery and Development.

Publications
Recent publications
Part of Proceedings of the National Academy of Sciences of the United States of America, 2024
- DOI for Antibiotic class with potent in vivo activity targeting lipopolysaccharide synthesis in Gram-negative bacteria
- Download full text (pdf) of Antibiotic class with potent in vivo activity targeting lipopolysaccharide synthesis in Gram-negative bacteria
Part of Basic & Clinical Pharmacology & Toxicology, p. 153-164, 2024
- DOI for Transfer of cetirizine/levocetirizine into human breast milk and estimation of drug exposure to infants through breastfeeding: A human lactation study from the ConcePTION project
- Download full text (pdf) of Transfer of cetirizine/levocetirizine into human breast milk and estimation of drug exposure to infants through breastfeeding: A human lactation study from the ConcePTION project
Part of Basic & Clinical Pharmacology & Toxicology, 2024
- DOI for Population pharmacokinetic modelling of cetirizine concentrations in human breast milk: A contribution from the ConcePTION project
- Download full text (pdf) of Population pharmacokinetic modelling of cetirizine concentrations in human breast milk: A contribution from the ConcePTION project
Part of Science Advances, 2024
- DOI for AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine-associated receptor 1
- Download full text (pdf) of AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine-associated receptor 1
Part of Journal of chromatography. B, 2022
All publications
Articles in journal
Part of Proceedings of the National Academy of Sciences of the United States of America, 2024
- DOI for Antibiotic class with potent in vivo activity targeting lipopolysaccharide synthesis in Gram-negative bacteria
- Download full text (pdf) of Antibiotic class with potent in vivo activity targeting lipopolysaccharide synthesis in Gram-negative bacteria
Part of Basic & Clinical Pharmacology & Toxicology, p. 153-164, 2024
- DOI for Transfer of cetirizine/levocetirizine into human breast milk and estimation of drug exposure to infants through breastfeeding: A human lactation study from the ConcePTION project
- Download full text (pdf) of Transfer of cetirizine/levocetirizine into human breast milk and estimation of drug exposure to infants through breastfeeding: A human lactation study from the ConcePTION project
Part of Basic & Clinical Pharmacology & Toxicology, 2024
- DOI for Population pharmacokinetic modelling of cetirizine concentrations in human breast milk: A contribution from the ConcePTION project
- Download full text (pdf) of Population pharmacokinetic modelling of cetirizine concentrations in human breast milk: A contribution from the ConcePTION project
Part of Science Advances, 2024
- DOI for AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine-associated receptor 1
- Download full text (pdf) of AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine-associated receptor 1
Part of Journal of chromatography. B, 2022
Imitation of β-lactam binding enables broad-spectrum metallo-β-lactamase inhibitors
Part of Nature Chemistry, p. 15-24, 2022
ENABLE: an engine for European antibacterial drug discovery and development
Part of Nature reviews. Drug discovery, p. 407-408, 2021
Part of Journal of Pharmaceutical Sciences, p. 2-11, 2021
Part of Scientific Reports, 2019
- DOI for Improved predictions of time-dependent drug-drug interactions by determination of cytosolic drug concentrations
- Download full text (pdf) of Improved predictions of time-dependent drug-drug interactions by determination of cytosolic drug concentrations
Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells
Part of Nature Communications, 2018
- DOI for Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells
- Download full text (pdf) of Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells
Part of Scientific Reports, 2018
- DOI for Anti-Rift Valley fever virus activity in vitro, pre-clinical pharmacokinetics and oral bioavailability of benzavir-2, a broad-acting antiviral compound
- Download full text (pdf) of Anti-Rift Valley fever virus activity in vitro, pre-clinical pharmacokinetics and oral bioavailability of benzavir-2, a broad-acting antiviral compound
Small-molecule inhibitor of OGG1 suppresses proinflammatory gene expression and inflammation
Part of Science, p. 834-839, 2018
Structure-metabolism-relationships in the microsomal clearance of piperazin-1-ylpyridazines
Part of MedChemComm, p. 1553-1560, 2017
Identification of Triazolothiadiazoles as Potent Inhibitors of the dCTP Pyrophosphatase 1
Part of Journal of Medicinal Chemistry, p. 2148-2154, 2017
Piperazin-1-ylpyridazine Derivatives Are a Novel Class of Human dCTP Pyrophosphatase 1 Inhibitors
Part of Journal of Medicinal Chemistry, p. 4279-4292, 2017
Validation and development of MTH1 inhibitors for treatment of cancer
Part of Annals of Oncology, p. 2275-2283, 2016
- DOI for Validation and development of MTH1 inhibitors for treatment of cancer
- Download full text (pdf) of Validation and development of MTH1 inhibitors for treatment of cancer
Discovery of the First Potent and Selective Inhibitors of Human dCTP Pyrophosphatase 1
Part of Journal of Medicinal Chemistry, p. 1140-1148, 2016
MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool
Part of Nature, p. 215-221, 2014
Part of European Journal of Clinical Pharmacology, p. 167-178, 2014